Jakarta, CNBC Indonesia – Banking shares controlled by financial technology (fintech) company Akulaku PT Bank Neo Commerce Tbk (BBYB) and issuers manufacturer of high-tech medical equipment and supplies (HiTech Healthcare Solutions), as well as swab antigen test products, PT Itama Ranoraya Tbk (IRRA), managed to become the top gainers in session I, Monday (28/6/2021).
Meanwhile, state-owned property issuer PT PP Properti Tbk (PPRO) and other companiesaham moving issuer in the field of digital trade marketing PT Digital Mediatama Maxima Tbk (DMMX) toppled over as a ‘loser’.
The Composite Stock Price Index (IHSG) started the week red until this afternoon. JCI fell 0.83% to 5,972,189 at the close of the first trading session on Monday (28/6).
According to IDX data, there were 154 rising shares, 335 declining shares and 128 immovable shares, with a transaction value of Rp 6.28 trillion and a trading volume of 10.05 billion shares.
Foreign investors in the stock market left the country’s stock exchange with a record foreign net selling of Rp 259.58 billion in the regular market. Meanwhile, foreigners recorded a net sale in the negotiating market and cash market of Rp 98.42 billion.
Here are the top 5 stock gainers and losers of session I today (28/6).
Top Gainers
-
MNC Studios International (MSIN), shares +15.24%, to Rp 242, transaction Rp 39.3 M
-
Yelooo Integra Datanet (YELO), +11.19%, to Rp 159, transaction Rp 9.6 M
-
Bank Neo Commerce (BBYB), +10.94%, to Rp 426, transaction Rp 29.9 M
-
Bank Syariah Indonesia (BRIS), +10.54%, to Rp 2,150, transaction Rp 592.0 M
-
Itama Ranoraya (IRRA), +9.41%, to Rp 1,860, transaction Rp 48.1 M
Top Losers
-
PP Properti (PPRO), shares -6.25%, to Rp 75, transaction Rp 11.6 M
-
International MNC Bank (BABP), -4.61%, to Rp 290, transaction Rp 48.4 M
-
MNC Investama (BHIT), -4.26%, to Rp 90, transaction Rp 33.8 M
-
Digital Mediatama Maxima (DMMX), -4,05%, to Rp 1,540, transaction Rp 42.5 M 42
-
Bumi Resources Minerals (BRMS), -3.74%, to Rp 103, transaction Rp 100.2 M
According to the data above, BBYB’s shares managed to soar 10.94% to Rp 426/share. With this, BBYB shares managed to stop the weakening trend since 2 days ago. As for the past week, this is the first time BBYB’s shares have turned green, after 3 times red and 2 times stagnant.
In a week this stock rose 0.95%, while in a month fell 6.17%.
The latest news, foreign investors Rockcore Financial Technology Co.Ltd again increases its shareholding in BBYB from the previous 4.05% to 6.12%.
In more detail, according to information disclosure on the Indonesia Stock Exchange (IDX) website, Rockcore Financial’s share ownership in this bank increased from 293,784,662 shares to 458,784,662 shares or an increase of 165 million shares.
Referring to data from the IDX, Rockcore Financial is domiciled in the Cayman Islands. The company has an office located in the same location as the Akulaku or PT Akulaku Silvrr Indonesia offices, namely at Sahid Sudirman Center Jl. Gen. Sudirman No. 86. No further information has been compiled on the internet regarding this company.
In addition to BBYB, IRRA’s shares also rose 9.41% to Rp 1,860/share. IRRA shares continued their gains since Friday (25/6) last week when they closed up 5.59%.
The strengthening of IRRA shares coincided with the increase in a number of other pharmaceutical stocks. The state-owned pharmaceutical stock duo, Indofarma (INAF) and Kimia Farma (KAEF), for example, rose 7.72% and 5.71%, respectively. Kalbe Farma (KLBF) and Phapros (PEHA) shares also rose by 2.95% and 2.59%, respectively.
The rise in these stocks occurred amid an increase in new cases of Covid-19 which again set a record high on Sunday (27/6) last week.
As of Sunday, the Ministry of Health recorded 2,093,962 positive corona patients. This figure increased by 21,095 people compared to the previous day, which was a record addition of daily cases since the first patient was announced on March 1, 2020.
performance in the first five months of this year, to be exact until May 2021 the company posted sales of Rp 331 billion or grew 366% YoY compared to the same period last year of Rp 71.02 billion.
Product in vitro in the form of antigen test is still the biggest contributor to the company’s sales. Other Abbott products such as Reagents and Plasma Machines were followed, namely Terumo. In the first semester of this year, sales were dominated by the retail segment (Non-APBN/APBD), and this has led to significant growth.
As for Itama’s performance in the first five months of this year, to be exact until May 2021, it was very positive. The company posted sales of Rp 331 billion or grew 366% YoY compared to the same period last year of Rp 71.02 billion.
Product in vitro in the form of antigen test is still the biggest contributor to the company’s sales. Other Abbott products such as Reagents and Plasma Machines were followed, namely Terumo. In the first semester of this year, sales were dominated by the retail segment (Non-APBN/APBD), and this has led to significant growth.
In contrast to fate, PPRO’s shares plunged 6.25% to Rp 75/share, continuing their decline last Friday when they fell 5.88%. Meanwhile, DMMX shares finally slumped 4.05% to Rp 1,540/share, stopping the rally from strengthening for 7 consecutive trading days. In a week DMMX shares jumped 9.61%.
CNBC INDONESIA RESEARCH TEAM
(adf/adf)
– .
